https://de.marketscreener.com/kurs/aktie/XINTELA-AB-39436427/news/Xintela-AB-publ-gibt-die-Verabreichung-des-ersten-Patienten-in-seiner-klinischen-Studie-uber-schw-45634499/?utm_source=telegram&utm_medium=social&utm_campaign=share